Dernières nouvelles pour Verve Therapeutics (NASDAQ:VERV) Stock

VERVE THERAPEUTICS INC

Verve Therapeutics

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.

Verve Therapeutics Inc

MGI MEDIA & GAMES INVEST by MGI MEDIA & GAMES INVEST SE

Verve Group SE

Ur-Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/URG#AMEX">URG</a>) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 57.14 percent increase over losses of $(0.07) per share from the same period last year.

Earnings

Earnings Misses

News

Ur-Energy Q1 EPS $(0.03) Misses $(0.02) Estimate

NFI Group (TSX:<a class="ticker" href="https://www.benzinga.com/stock/NFI#TSX">NFI</a>) affirms FY2025 sales outlook from $3.80 billion-$4.20 billion to $3.80 billion-$4.20 billion.

Guidance

TSX:NFI

NFI Group Affirms FY2025 Sales Guidance of $3.80B-$4.20B

Serve Robotics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) reported financial results for the first quarter after the market close on Thursday. Here&#8217;s a look at <a href="https://www.benzinga.com/pressreleases/25/05/g45298957/serve-robotics-announces-first-quarter-2025-results">the key highlights</a>.
Q1 Earnings: Serve Robotics reported first-quarter revenue of $440,460, missing analyst <a href="http://benzinga.com/quote/serv/earnings">estimates</a> of $486,670, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported a first-quarter adjusted loss of 16 cents per share, beating estimates for a loss of 20 cents per share.
Total revenue was up 150% on a quarter-over-quarter basis. The company said it built over 250 new third-generation robots by the end of the period. Delivery volume increased over 75% between the first and last week of the first quarter, driven by increased capacity and utilization. 
Serve Robotics ended the quarter with $198 million in cash, which the company expects to provide runway through the end of 2026. 
&#8220;With this momentum, we remain on track to deploy 2,000 robots by year-end. Our ability to maintain high delivery quality while rapidly expanding delivery volume, geographic reach and merchant partnerships reflects our team&#8217;s relentless focus and execution,&#8221; said Ali Kashani, co-founder and CEO of Serve Robotics.
Outlook: Serve Robotics guide for second-quarter revenue of $600,000 to $700,000 based on estimated delivery volume growth of approximately 60% to 75% quarter-over-quarter.
Serve Robotics continues to expect an annualized revenue run-rate of $60 million to $80 million once its fleet of 2,000 robots is fully deployed and reaches target utilization, which is expected in 2026. The company plans to build at least 700 reduced-cost third-generation robots in the third quarter and the remainder in the fourth quarter.
SERV Price Action: <a href="http://benzinga.com/quote/serv">Serve Robotics shares</a> were down 5.03% after hours, trading at $6.23 at the time of publication on Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45303071/wolfspeed-stock-slides-after-q3-revenues-miss-estimates-heres-what-to-know">Wolfspeed Stock Slides After Q3 Revenues Miss Estimates: Here&#8217;s What To Know</a></li>
</ul>
Photo: courtesy of Serve Robotics.

After-Hours Center

Movers

Tech

SERV

Serve Robotics Stock Slides On Mixed Q1 Earnings, Company Expects To Deploy 2,000 Robots By Year-End

Golden Matrix Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMGI#NASDAQ">GMGI</a>) sees FY2025 sales of $190.000 million-$195.000 million vs $199.25 million analyst estimate.

GMGI

Golden Matrix Group Sees FY2025 Sales $190.000M-$195.000M vs $199.25M Est

Artis REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AX#TSX">AX</a>) reported quarterly earnings of $0.17 per share. This is a 30.77 percent increase over earnings of $0.13 per share from the same period last year. The company reported $62.30 million in sales this quarter. This is a 22.53 percent decrease over sales of $80.42 million the same period last year.

TSX:AX

Artis REIT Q1 FFO $0.17 Up From $0.13 YoY, Sales $62.30M Down From $80.42M YoY

Sangoma Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANG#NASDAQ">SANG</a>) narrows FY2025 sales outlook from $235.00 million-$240.00 million to $235.00 million-$238.00 million vs $236.94 million estimate.

SANG

Sangoma Technologies Narrows FY2025 Sales Guidance from $235.00M-$240.00M to $235.00M-$238.00M vs $236.94M Est

Franco-Nevada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNV#NYSE">FNV</a>) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $1.00 by 7 percent. This is a 40.79 percent increase over earnings of $0.76 per share from the same period last year. The company reported quarterly sales of $368.40 million which beat the analyst consensus estimate of $311.02 million by 18.45 percent. This is a 43.46 percent increase over sales of $256.80 million the same period last year.

Earnings Beats

Franco-Nevada Q1 Adj. EPS $1.07 Beats $1.00 Estimate, Revenue $368.40M Beat $311.02M Estimate

Sun Life Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLF#NYSE">SLF</a>) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1.22 by 4.1 percent. This is a 14.41 percent increase over earnings of $1.11 per share from the same period last year. The company reported quarterly sales of $7.91 billion which beat the analyst consensus estimate of $6.44 billion by 22.78 percent. This is a 55.01 percent increase over sales of $5.10 billion the same period last year.

Sun Life Financial Q1 Adj. EPS $1.27 Beats $1.22 Estimate, Sales $7.91B Beat $6.44B Estimate

American Realty Investors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARL#NYSE">ARL</a>) reported quarterly earnings of $0.18 per share. This is a 63.64 percent increase over earnings of $0.11 per share from the same period last year. The company reported $12.01 million in sales this quarter. This is a 0.92 percent increase over sales of $11.90 million the same period last year.

American Realty Investors Q1 EPS $0.18 Up From $0.11 YoY, Sales $12.01M Up From $11.90M YoY

Transcontinental Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TCI#NYSE">TCI</a>) reported quarterly earnings of $0.53 per share. This is a 76.67 percent increase over earnings of $0.30 per share from the same period last year. The company reported $12.01 million in sales this quarter. This is a 0.92 percent increase over sales of $11.90 million the same period last year.

Transcontinental Realty Q1 EPS $0.53 Up From $0.30 YoY, Sales $12.01M Up From $11.90M YoY

OneStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OS#NASDAQ">OS</a>) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.03) by 233.33 percent. The company reported quarterly sales of $136.31 million which beat the analyst consensus estimate of $131.36 million by 3.76 percent.

CORRECTION: OneStream Q1 Adj. EPS $0.04 Beats $(0.03) Estimate, Sales $136.31M Beat $131.36M Estimate

Franco-Nevada (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FNV#TSX">FNV</a>) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $1.00 by 7 percent. This is a 40.79 percent increase over earnings of $0.76 per share from the same period last year. The company reported quarterly sales of $368.40 million which beat the analyst consensus estimate of $333.27 million by 10.54 percent. This is a 43.46 percent increase over sales of $256.80 million the same period last year.

TSX:FNV

Franco-Nevada Q1 Adj. EPS $1.07 Beats $1.00 Estimate, Sales $368.40M Beat $333.27M Estimate

Unusual Machines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#AMEX">UMAC</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.12) by 75 percent. This is a 16.67 percent decrease over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $2.04 million which beat the analyst consensus estimate of $1.50 million by 36.13 percent. This is a 229.93 percent increase over sales of $618.91 thousand the same period last year.

UMAC

CORRECTION: Unusual Machines Q1 EPS $(0.21) Misses $(0.12) Estimate, Sales $2.04M Beat $1.50M Estimate

Koss (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOSS#NASDAQ">KOSS</a>) reported quarterly losses of $(0.03) per share. This is unchanged from the same period last year. The company reported $2.78 million in sales this quarter. This is a 5.44 percent increase over sales of $2.64 million the same period last year.

KOSS

Koss Q3 EPS $(0.03), Same YoY, Sales $2.78M Up From $2.64M YoY

CLSK

CleanSpark Q2 Bitcoin Production Grew To 1,957, With An Average Revenue Per Coin of $92,811

Insight Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSIT#NASDAQ">NSIT</a>) has outperformed the market over the past 15 years by 4.34% on an annualized basis producing an average annual return of 15.61%. Currently, Insight Enterprises has a market capitalization of $4.33 billion. 
Buying $1000 In NSIT: If an investor had bought $1000 of NSIT stock 15 years ago, it would be worth $8,628.48 today based on a price of $136.33 for NSIT at the time of writing.
<h3>Insight Enterprises's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746739827_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

NSIT

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Income Opportunity Realty (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IOR#AMEX">IOR</a>) reported quarterly earnings of $0.24 per share. This is a 17.24 percent decrease over earnings of $0.29 per share from the same period last year.

Income Opportunity Realty Q1 EPS $0.24 Down From $0.29 YoY

Balance Sheet Highlights as of March 31, 2025
Assets
<ul>
<li>Cash: $97.0 million</li>
<li>Bitcoin: $979.6 million</li>
<li>Total Current Assets: $947.5 million</li>
<li>Total Mining Assets (including prepaid deposits &amp; deployed miners): $899.6 million</li>
<li>Total Assets: $2.7 billion</li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

CleanSpark Q2 Bitcoin Balance $979.6M

Tucows (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCX#NASDAQ">TCX</a>) reported quarterly losses of $(1.37) per share. This is a 43.39 percent increase over losses of $(2.42) per share from the same period last year. The company reported $94.61 million in sales this quarter. This is a 8.18 percent increase over sales of $87.46 million the same period last year.

Tucows Q1 EPS $(1.37) Up From $(2.42) YoY, Sales $94.61M Up From $87.46M YoY

Golden Matrix Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMGI#NASDAQ">GMGI</a>) reported quarterly sales of $42.72 million which missed the analyst consensus estimate of $43.12 million by 0.91 percent. This is a 260.71 percent increase over sales of $11.84 million the same period last year.

Golden Matrix Group Q1 Sales $42.72M Miss $43.12M Estimate

Press Releases

Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law Firm

Health Care

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

General

Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose

Management

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Comments

Verve Therapeutics

Actualités

Dernières nouvelles pour Verve Therapeutics (NASDAQ:VERV) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL